-
-
-
-
-
-
-
Agenus advances cancer drug combo to phase 3, reports early revenue
-
-
-
-
-
-
-
Agenus to Provide Corporate Update and Second Quarter 2025 Financial Report
-
-
-
-
-
-
-
Agenus Inc. (AGEN) PT Lowered to $7 at H.C. Wainwright
-
-
-
-
-
-
-
Ligand Reports Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report
-
-
-
-
-
-
-
Agenus Provides Corporate Update and First Quarter 2023 Financial Results
-
-
-
-
-
-
-
Agenus (AGEN) Misses Q3 EPS by 1c
-
1,214,511 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

